Logo for Nirvana Life Sciences Inc.
NIRV.X

Nirvana Life Sciences Inc.

Status
Active
Issued & Outstanding22,823,301
Reserved for Issuance690,000
Currency
CSE Index

About

Nirvana Life Sciences Inc.

Listing Date
March 17, 2022
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.